Bio News
-
Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | Information Technology
Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals
Supporting R&D optimization of next-generation biopharmaceuticals with digital technology and drug discovery platform.Tim Wright, Editor, Contract Pharma 04.07.21
-
Bio News | Breaking News | Cytotoxics and High Potency Manufacturing | Facilities | Industry News
Sterling Pharma Solutions Acquires ADC Biotechnology
Will establish a center of excellence for bioconjugation and ADC development and manufacturing services.Tim Wright, Editor, Contract Pharma 04.07.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | Parenterals
Sanofi to Build New $700M Flu Vaccine Facility in Canada
Facility will be located in Toronto and will increase supply of influenza vaccines in Canada, the U.S. and Europe.Tim Wright, Editor, Contract Pharma 04.05.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Fill/Finish | Industry News
GSK Supports Manufacture of Novavax’ COVID-19 Vaccine
GSK will provide fill and finish manufacturing capacity for up to 60 million doses at its Barnard Castle facility.Tim Wright, Editor, Contract Pharma 03.31.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Facilities | Industry News
Chime Biologics Expands CDMO Capabilities
Completes $190 million financing round to accelerate capacity expansion.Tim Wright, Editor, Contract Pharma 03.29.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Fill/Finish | Industry News | Parenterals
Jubilant, Novavax Enter COVID-19 Vaccine Partnership
Jubilant to provide fill-finish manufacturing services for the production of COVID-19 vaccine candidate NVX-CoV2373.Tim Wright, Editor, Contract Pharma 03.29.21
-
Bio News | Biosimilars | Breaking News | cGMP Manufacture | Collaborations & Alliances | Facilities | Industry News
mAbxience Bolsters Biosimilar and CDMO Manufacturing Capacity
Utilizing ABEC Custom Single Run technology to increase flexibility and productivity.Tim Wright, Editor, Contract Pharma 03.25.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
BioCentriq and Kytopen Enter Cell Therapy Partnership
To show the impact to autologous and allogeneic cell therapies by integrating novel transfection technology with other steps in the manufacturing process.Tim Wright, Editor, Contract Pharma 03.23.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
RDIF & Stelis Enter Covid-19 Vaccine Supply Deal
Partner to supply 200 million doses of the Sputnik V vaccine.Tim Wright, Editor, Contract Pharma 03.19.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News | Parenterals
Genopis Renamed Wacker Biotech US
Plasmid DNA contract manufacturer was recently acquired by Wacker.Tim Wright, Editor, Contract Pharma 03.19.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Fujifilm Selects North Carolina for $2B Bio CDMO Facility
Holly Springs is the location chosen to build the largest cell culture biopharmaceutical CDMO facility in North America.Tim Wright, Editor, Contract Pharma 03.19.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Catalent Expands Partnership with J&J
To significantly increase capacity for sterile manufacturing and packaging of COVID-19 vaccine in Italy.Tim Wright, Editor, Contract Pharma 03.17.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Fujifilm and Sana Biotechnology Enter Cell Therapy Partnership
Enter license agreement for the development of iPSC-derived cell therapies.Tim Wright, Editor, Contract Pharma 03.17.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News | Parenterals
WuXi Biologics to Acquire Manufacturing Facilities from Pfizer China
Immediately boosts commercial Drug Substance and Drug Product capacities for WuXi Biologics to address surging manufacturing demands.Tim Wright, Editor, Contract Pharma 03.17.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Takeda and IDT Support Manufacturing of J&J’s COVID-19 Vaccine
Will make manufacturing capacity available at IDT’s facilities in Germany to manufacture the single-shot COVID-19 vaccine.Tim Wright, Editor, Contract Pharma 03.15.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Maravai Expands CDMO Capabilities Through TriLink Biotechnologies
Offers end-to-end mRNA production with the launch of TriLink's plasmid DNA manufacturing services.Tim Wright, Editor, Contract Pharma 03.15.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
BioVaxys, Wuxi Biologics Enter Bioproduction Agreement
To synthesize proteins for SARS-CoV-2 vaccine and COVID-T immunodiagnostic programs.Tim Wright, Editor, Contract Pharma 03.15.21
-
APIs | Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Industry News
PhaseBio and BioVectra Enter into Supply Agreement
To support development and commercialization of bentracimab.Tim Wright 03.11.21
-
Bio News | Breaking News | Industry News
NMPA Accepts Application for Clinical Trial of Bifunctional Fusion Protein
JS201, developed by Junshi Biosciences, can simultaneously target PD-1 and TGF-β.Charles Sternberg, Assistant Editor 03.09.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
High Purity New England & Univercells Technologies Unveil Bioprocessing Solutions
New highly scalable line of bioreactors designed to ensure seamless scalability from early process development to commercial manufacturing.Tim Wright, Editor, Contract Pharma 03.09.21
